Maalox, 15 ml suspension 30 pcs

Pharmaceutical group:

antacid.

Pharmic action:

Aluminum hydroxide and magnesium hydroxide neutralize free hydrochloric acid of gastric juice without causing its secondary hypersecretion. In addition, increase of gastric juice pH while taking Maalox® leads to decrease of pepsin activity in gastric juice.

The drug also has adsorptive and coating effect, due to which the impact of damaging factors on the mucous membrane of the esophagus and the stomach is reduced.

Pharmacokinetics:

Magnesium hydroxide and aluminum hydroxide are considered topical antacids. Because of low absorption, they have no systemic action.

Indications

acute gastroduodenitis;
peptic ulcer of the stomach and duodenum in the acute phase;
chronic gastroduodenitis with normal or increased secretory function in the acute phase;
hiatal hernia;
reflux esophagitis;
phenomena of dyspepsia (and their prevention) resulting from the use of certain medications (including NSAIDs, corticosteroids);
discomfort or pain in the epigastrium, heartburn due to errors in diet, excessive consumption of coffee, alcohol, nicotine.

Pharmacological effect

Pharmgroup:

antacid.

Pharmaceutical action:

Aluminum hydroxide and magnesium hydroxide neutralize free hydrochloric acid of gastric juice without causing its secondary hypersecretion. In addition, an increase in the pH of gastric juice when taking the drug Maalox® leads to a decrease in the activity of pepsin in gastric juice.

The drug also has an adsorbing and enveloping effect, which reduces the impact of damaging factors on the mucous membrane of the esophagus and stomach.

Pharmacokinetics:

Magnesium hydroxide and aluminum hydroxide are considered topical antacids. Due to low absorption they do not have a systemic effect.

Special instructions

When prescribing the drug to children, the dosage regimen is determined individually; It is not recommended to use the drug in children under 12 years of age without consulting a doctor.

Active ingredient

Algeldrat, Magnesium hydroxide

Composition

15 ml of suspension contains:

Pregnancy

Contraindicated during pregnancy and breastfeeding.

Contraindications

hypophosphatemia;
severe renal failure;
fructose intolerance (due to the presence of sorbitol in the drug);
hypersensitivity to active substances and other components of the drug;
childhood and adolescence up to 15 years.

Side Effects

Metabolic and nutritional disorders: unknown frequency – hypermagnesemia, hyperaluminemia, hypophosphatemia (with long-term treatment or taking high doses, or when taking standard doses with low phosphate content in food), which can lead to increased bone resorption, hypercalciuria, osteomalacia.

Interaction

With simultaneous use, Maalox may increase the level of quinidine in the blood plasma, which increases the risk of overdose.

Overdose

Symptoms of acute overdose with a combination of magnesium salts and aluminum hydroxide include diarrhea, abdominal pain and vomiting.

Storage conditions

Store out of the reach of children at a temperature not exceeding 25°C.

Shelf life

3 years

Manufacturer

Pharmatis, France